Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help ...

It’s no surprise that pharma research and development (R&D) remains one of the most important hubs for innovation. Every pharma company invests heavily in and relies on R&D teams to create new ...

Detailed price information for Lantern Pharma Inc (LTRN-Q) from The Globe and Mail including charting and trades.

As the excitement around generative AI sweeps across the globe, biopharma R&D groups (like most everyone else) are actively trying to figure out how to leverage this powerful but nascent technology ...

AI is fundamentally transforming life sciences, with the potential to impact many aspects of the industry’s value chain -- from drug discovery to manufacturing. These AI applications are already ...

A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector is positive, with 49% of pharmaceutical and biotechnology ...

Agentic AI enables autonomous, goal-driven coordination of AI agents, enhancing decision-making in data-rich industries like life sciences. The technology allows AI agents to reason, adapt, and ...

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce ...